Figure 6

Plasma levels of anti von Willebrand factor (anti-VWF) autoantibodies expressed as absorbance (Abs) at 492 nm in plasma from the patient with acquired von Willebrand syndrome before and after starting treatment with high dose intravenous immunoglobulin (Ig). The dotted line represents the upper limit of the normal range.